Nasdaq(NDAQ)
Search documents
Nasdaq Calypso to Ease Novobanco's Capital Market Operations
ZACKS· 2025-01-16 18:00
Nasdaq Inc. (NDAQ) announced that it has extended its partnership with Novobanco, Portugal’s fourth-largest bank. This partnership enables Novobanco to deploy Nasdaq’s Calypso platform to support the bank’s entire capital market operations.Novobanco, for over two decades, has been using the platform to conduct back-office processing. With the extended partnership, the bank will now use the platform for risk and front-office functionality. Nuno Duarte, head of Treasury and Finance Novobanco, stated, “Consoli ...
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfile· 2025-01-16 18:00
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 16, 2025 1:00 PM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - January 16, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it ...
Nasdaq 100: Tesla Falls 3.7% as Tech Slides on Bessent's Tax Cut Warning
FX Empire· 2025-01-16 17:21
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq, S&P 500 to extend gains after soft core inflation reading
Proactiveinvestors NA· 2025-01-16 11:48
About this content About Josh Lamb After graduating from the University of Kent in the summer of 2022 with a degree in History, Josh joined Proactive later that year as a journalist in the UK editorial team. Josh has reported on a range of areas whilst at Proactive, including energy companies during a time of global crisis, aviation and airlines as the sector recovers from the pandemic, as well as covering economic, social and governance issues. Read more About the publisher Proactive financial news and ...
Should You Buy the Dip in Nasdaq ETFs?
ZACKS· 2025-01-15 20:00
Wall Street is off to a wobbly start in 2025 due to speculation that the Fed may limit the scope for further interest-rate cuts amid a strong economy and expectations for higher inflation. The Nasdaq-100 exchange-traded fund (ETF) Invesco QQQ Trust (QQQ) has lost about 1.7% so far this year (as of Jan. 14, 2025).Should You Buy the Dip in Nasdaq?BlackRock’s Rick Rieder would “100%” buy the Nasdaq dip, as quoted on CNBC. Investors should note that the Nasdaq plunged more than 30% in 2022 but overcame the down ...
Why I'm Still Choosing To Invest In The Nasdaq-100 With QQQM
Seeking Alpha· 2025-01-15 13:30
Over the past five years, the "Magnificent 7" have consistently delivered double-digit earnings and revenue growth (see chart above). These stocks have also been the primary drivers of the US stock market’s returns, and as a result, US tech companies are recognized for their innovationInvestor based in Geneva, Switzerland. Follow me on Twitter @GenevaInvestor for daily macro & investing nuggets. I write about macroeconomics, global trends, and what I believe are asymmetric investment opportunities in the ma ...
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfile· 2025-01-15 12:00
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 15, 2025 7:00 AM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - January 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it h ...
2 Nasdaq-100 Stocks That Are No-Brainer Buys in 2025, and 1 to Avoid
The Motley Fool· 2025-01-15 10:06
Among the 100 companies that comprise the growth-centric Nasdaq-100 are two decisively inexpensive brand-name stocks, as well as a recent addition trading at an unjustifiable premium.The second year of Wall Street's bull market rally didn't disappoint. Although all three major stock indexes climbed to numerous record-closing highs throughout 2024, it's growth stocks that continued to lead the charge.The Nasdaq-100, which is comprised of 100 of the largest non-financial public companies listed on the Nasdaq ...
Novobanco Expands Technology Partnership with Nasdaq Calypso to Simplify its Capital Market Operations
Newsfilter· 2025-01-15 07:00
Partnership Expansion - Novobanco, Portugal's 4th largest bank, expands its partnership with Nasdaq by adopting Nasdaq's Calypso Front Office and Risk platform to fully integrate its treasury infrastructure [1] - The fully integrated system will be deployed in the cloud, enhancing flexibility and scalability for Novobanco's capital market operations [1] - This marks a significant milestone in Novobanco's ongoing transformation, positioning the bank to meet new industry standards and capitalize on growth opportunities [4][8] Nasdaq's Technology and Market Position - Nasdaq's Calypso platform is used by 97% of global systematically important banks, 50% of the world's top 25 stock exchanges, 35 central banks, and over 3,500 clients in the financial services industry [2] - Nasdaq's technology expertise and cloud-managed services help financial institutions solve operational challenges and advance industry modernization [2] - Nasdaq Calypso is a global, multi-asset trade management platform designed to streamline trading, clearing, risk management, and post-trade processing [8] Novobanco's Transformation and Strategy - Novobanco aims to become a client-centric bank, focusing on providing a seamless and efficient customer experience supported by an expert team [5] - The bank has been simplifying and improving its IT and data governance functions, reformulating its operating model, and meeting regulatory commitments [5] - Novobanco's treasury workflows, including trade settlement, payment, and accounting processes, are already supported by Nasdaq Calypso, with expansion to front-office and risk functions creating an efficient, integrated system [9] Novobanco's Market Position and Operations - Novobanco is the 4th largest bank in Portugal, with 1.6 million customers, assets of €45.6 billion, and a 9.3% market share as of September 2024 [10] - The bank operates 291 branches and 20 corporate centers, offering an omnichannel customer relationship model with secure digital channels and a proximity distribution model [10] - Novobanco values the training of its 4,200+ professionals and supports community initiatives through social, cultural, and financial inclusion programs [6]
Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
Prnewswire· 2025-01-14 22:50
Delisting and Appeal - Nature's Miracle Holding Inc received a notice from Nasdaq indicating the delisting of its common stock and warrants due to non-compliance with the minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1) [1] - Trading of the Company's common stock and warrants will be suspended on Nasdaq effective at the open of business on January 15, 2025 [1] - The Company has 15 days to request a review of the decision by the Nasdaq Listing and Hearing Review Council, or the Council may independently review the decision within 45 calendar days [2] - The Company is considering appealing the decision [2] Post-Suspension Trading - Upon suspension on Nasdaq, the Company expects its common stock and warrants to be quoted under the symbols "NMHI" and "NMHW" respectively on the OTC Pink market [3] Company Overview - Nature's Miracle Holding Inc is an agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (CEA) industry globally [4] - The Company has recently expanded into EV and bitcoin businesses, both of which are energy-dependent like CEA [4] Forward-Looking Statements - The press release contains forward-looking statements regarding the Company's future expectations, strategies, and plans, including product development, business growth, and market acceptance [5] - These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially [5][6]